Related Experiment Video
Updated: Mar 29, 2026
08:44
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
1.5K
Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance
Linnea Jarenbäck1, Jaro Ankerst1, Leif Bjermer1
1Dept. of Clinical Sciences, Lund, Lund University, 221 84 Lund, Sweden.
Respiratory Medicine
|November 27, 2015
Summary
This study found that acinar airway heterogeneity (Sacin) increases with COPD severity and correlates with lung function parameters like diffusion capacity. Bronchodilators did not affect this heterogeneity.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is characterized by airflow limitation.
- Ventilation heterogeneity, particularly in acinar airways, is a key feature of COPD.
- Impulse Oscillometry (IOS) offers advanced lung function insights.
Purpose of the Study:
- To investigate acinar (Sacin) and conductive (Scond) airway heterogeneity in COPD patients across different severities.
- To correlate Sacin and Scond with advanced lung function parameters measured by IOS.
- To assess the impact of bronchodilators on ventilation heterogeneity in COPD.
Main Methods:
- Recruited never-smoking controls, smoking controls, and COPD patients (GOLD 1-4).
- Utilized spirometry, IOS, body plethysmography, diffusion capacity testing, and N2-multiple breath washout.
- Administered bronchodilator reversibility tests (salbutamol and ipratropium).
Main Results:
- Acinar airway heterogeneity (Sacin) was significantly elevated in GOLD 2-4 COPD patients compared to controls.
- Sacin levels were similar in GOLD 3 and 4 patients.
- No significant effect of short-acting bronchodilators on Sacin or Scond was observed.
- Factor analysis revealed associations between Sacin, diffusion parameters, lung volumes, and IOS measures.
Conclusions:
- Increased acinar airway heterogeneity in COPD is linked to impaired diffusion capacity and altered lung volumes.
- Ventilation heterogeneity in acinar airways correlates with IOS parameters.
- Bronchodilators do not acutely modify ventilation heterogeneity in COPD patients.
Related Concept Videos
01:19Factors Affecting Pulmonary Ventilation
3.7K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:24External and Internal Respiration
8.7K
External respiration occurs in the lungs, and it is the first step in the journey of oxygen inside the body. When we inhale, oxygen enters our lungs and diffuses across the thin alveolar membrane. The alveoli are tiny, air-filled sacs that provide a vast surface area for gas exchange. Oxygen in the alveoli has a higher partial pressure (105 mmHg) than in the adjacent pulmonary capillaries (40 mmHg), establishing a pressure gradient. As a result, oxygen molecules move from the alveoli into the...
8.7K
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K